We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More
A study led by researchers at NYU School of Medicine has revealed that a new computer program can analyze images of patients’ lung tumors, specify cancer types, and find altered genes driving abnormal cell growth.
Siemens Healthineers has completed the installation of its newest ultrasound system, the Acuson Sequoia, at Baptist Health South Florida in the US.
AngioDynamics has signed an agreement to acquire medical diagnostic and device firm, RadiaDyne, for an undisclosed sum.
Researchers from Chalmers University of Technology, Sweden, have developed a new testing device using bone conduction technology, that offers significant advantages over the existing tests.
Philips has installed its new MRI system Ingenia Ambition X1.5T MR at Spital Uster Hospital, in Zurich, Switzerland.
Tiny microbubbles are being utilized to more effectively treat liver cancer, according to a pilot study.
Medical technology firm Boston Scientific has agreed to acquire US-based prostate therapy developer Augmenix in an agreement valued at around $600m.
Royal Philips has announced the latest release of TissueMark, which now supports region of interest detection for the majority of molecular testing and helps research labs improve the accuracy of tumor estimation.
Cambridge Consultants has collaborated with Exact Imaging to apply artificial intelligence (AI) to better visualize and detect prostate cancer.
Health technology firm Royal Philips has signed two partnership agreements in Australia for medical imaging solutions.
Free Medical Devices WebinarsSign up to watch our free medical devices industry webinars.
Get the Medical Devices newsletterSign up to our free email to get all the latest medical devices news.